Immunogenicity and reactogenicity following MMR vaccination in 5-7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infants.

Autor: Vittrup DM; The Child and Adolescent Department, The University Hospital Herlev, Denmark.; The Child and Adolescent Clinic, The Juliane Marie Centre, The Danish National University Hospital 'Rigshospitalet', Denmark., Jensen A; The Child and Adolescent Clinic, The Juliane Marie Centre, The Danish National University Hospital 'Rigshospitalet', Denmark., Sørensen JK; The Child and Adolescent Clinic, The Juliane Marie Centre, The Danish National University Hospital 'Rigshospitalet', Denmark., Zimakoff AC; The Child and Adolescent Clinic, The Juliane Marie Centre, The Danish National University Hospital 'Rigshospitalet', Denmark., Malon M; The Child and Adolescent Clinic, The Juliane Marie Centre, The Danish National University Hospital 'Rigshospitalet', Denmark., Charabi S; Department of Cardiology, Nordsjaellands Hospital, Hilleroed, Denmark., Johansen MR; Department of Gynecology and Obstetrics, Nykoebing Falster Hospital, Denmark., Simões EAF; School of Medicine, and Colorado School of Public Health, University of Colorado, Aurora, Colorado, USA., Kirkby NS; Dept. of Microbiology, The Danish National University Hospital 'Rigshospitalet', Denmark., Buus S; Dept. of Immunology, University of Copenhagen, Denmark., Svensson J; The Child and Adolescent Department, The University Hospital Herlev, Denmark.; Steno Diabetes Centre Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Denmark., Stensballe LG; The Child and Adolescent Clinic, The Juliane Marie Centre, The Danish National University Hospital 'Rigshospitalet', Denmark.; Department of Clinical Medicine, University of Copenhagen, Denmark.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2024 Jan 12; Vol. 68, pp. 102421. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2024).

Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.

Autor: Charabi S; Department of Neurology, University of Copenhagen Herlev Hospital, Herlev, Denmark., Engell-Noerregaard L; Department of Oncology, University of Copenhagen Herlev Hospital, Herlev, Denmark., Nilsson AC; Autoimmune Laboratory, Department of Clinical Immunology, Odense University Hospital, Odense, Denmark., Stenör C; Department of Neurology, University of Copenhagen Herlev Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Frontiers in neurology [Front Neurol] 2021 Apr 30; Vol. 12, pp. 655283. Date of Electronic Publication: 2021 Apr 30 (Print Publication: 2021).

Erratum:Growth of vestibular schwannomas: In situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry (The American Journal of Otology, 17 (1996) (301-306))

Autor: Charabi, S., Engel, P., Charabi, B., Krag Jacobsen, G., Overgaard, J., Thomsen, J., Tos, M.

Publikováno v: Charabi, S, Engel, P, Charabi, B, Krag Jacobsen, G, Overgaard, J, Thomsen, J & Tos, M 1996, ' Erratum : Growth of vestibular schwannomas: In situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry (The American Journal of Otology, 17 (1996) (301-306)) ', American Journal of Otology, vol. 17, no. 4, pp. 692 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::5efe779f4db0312bb32e01d2ddac4db3
https://pure.au.dk/portal/da/publications/erratum(e391a5db-fd6e-45c6-a4f6-1cb1c76fc647).html

Incidence of vestibular schwannoma in Denmark, 1977-1995

Autor: Mf, Howitz, Johansen C, Tos M, Charabi S, Jørgen Helge Olsen

Publikováno v: Europe PubMed Central

To establish the incidence rate of vestibular schwannomas (VS) (acoustic neuromas) in Denmark.The worldwide incidence rates of VS vary from 1 to 20 cases per million population per year.The nationwide and population-based age-specific, sex-specific,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::56d9ae012f4b81ef61a216529189bde4
https://pubmed.ncbi.nlm.nih.gov/10993460

Bevacizumab Treatment for Patients with NF2 -Related Schwannomatosis: A Single Center Experience.

Autor: Douwes, Jules P. J.¹ (AUTHOR) e.f.hensen@lumc.nl, Hensen, Erik F.¹ (AUTHOR) j.c.jansen@lumc.nl, Jansen, Jeroen C.¹ (AUTHOR), Gelderblom, Hans² (AUTHOR) a.j.gelderblom@lumc.nl, Schopman, Josefine E.² (AUTHOR) j.e.schopman@lumc.nl

Publikováno v: Cancers. Apr2024, Vol. 16 Issue 8, p1479. 14p.